BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10731951)

  • 21. [Impulse cytophotometric studies of bone marrow and blood cells in children with acute lymphoblastic leukemia (ALL). 1. Bone marrow cells].
    Exadaktylos P; Schlette O; Rumler W; Weidhase R; Haerting J; Reiss T; Heinrichs I
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1987; 114(4):530-41. PubMed ID: 2446994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro secretion of matrix metalloprotease 9 is a prognostic marker in childhood acute lymphoblastic leukemia.
    Schneider P; Costa O; Legrand E; Bigot D; Lecleire S; Grassi V; Vannier JP; Vasse M
    Leuk Res; 2010 Jan; 34(1):24-31. PubMed ID: 19748669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study on clinical features between TEL-AML1 positive and negative childhood acute lymphoblastic leukemia].
    Guo X; Li Q; Zhu YP; Zhou CY; Gao J; Li XH; Pan LL; Li FY; Tian X; Liu HT
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Oct; 24(5):560-3. PubMed ID: 17922427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bone marrow cellularity in acute lymphoblastic leukemia of children].
    Styczyński J; Kubicka M; Langer B; Wysocki M; Debski R; Wolska E; Polańska M
    Wiad Lek; 2000; 53(9-10):507-12. PubMed ID: 11148917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic significance of DNA index by flowcytometry in acute lymphoblastic leukaemia.
    Parikh PM; Ashokkumar MS; Pai SK; Redkar A; Chopra HK; Barbhaya SA; Gopal R; Mittra I; Advani SH
    Indian J Med Res; 1995 Jul; 102():24-7. PubMed ID: 7558206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
    Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
    [No Abstract]   [Full Text] [Related]  

  • 27. A demographic study of the clinical significance of minimal residual disease in children with acute lymphoblastic leukemia.
    Levett D; Middleton P; Cole M; Reid MM
    Med Pediatr Oncol; 2001 Mar; 36(3):365-71. PubMed ID: 11241438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between the bone marrow cell proliferation and the prognosis in childhood acute lymphoblastic leukemia].
    Zheng H; Zhao X; Geng L
    Zhonghua Xue Ye Xue Za Zhi; 1999 Jan; 20(1):7-9. PubMed ID: 11498846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Study of antigenic profile of blasts in acute lymphoblastic leukemia: flow cytometric analysis of 152 cases].
    Jmili NB; Souguir S; Yacoub S; Khelif A; Kortas M
    Ann Biol Clin (Paris); 2009; 67(5):543-51. PubMed ID: 19789126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR; Ross CW; Finn WG; Schnitzer B; Singleton TP
    Hum Pathol; 2000 Sep; 31(9):1051-4. PubMed ID: 11014570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognosis of acute lymphoblastic leukemia in children. Results of the French protocol FRALLE 93].
    Schaison G; Auclerc MF; Baruchel A; Leblanc T; Leverger G
    Bull Acad Natl Med; 2001; 185(1):149-60; discussion 160-2. PubMed ID: 11474564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia.
    Schwarz AK; Stanulla M; Cario G; Flohr T; Sutton R; Möricke A; Anker P; Stroun M; Welte K; Bartram CR; Schrappe M; Schrauder A
    Ann Hematol; 2009 Sep; 88(9):897-905. PubMed ID: 19165483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].
    Magrath I; Shanta V; Advani S; Adde M; Arya LS; Banavali S; Bhargava M; Bhatia K; Gutiérrez M; Liewehr D; Pai S; Sagar TG; Venzon D; Raina V
    Eur J Cancer; 2005 Jul; 41(11):1570-83. PubMed ID: 16026693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors for relapsed childhood acute lymphoblastic leukemia: impact of allogeneic stem cell transplantation--a report from the Kyushu-Yamaguchi Children's Cancer Study Group.
    Matsuzaki A; Nagatoshi Y; Inada H; Nakayama H; Yanai F; Ayukawa H; Kawakami K; Moritake H; Suminoe A; Okamura J
    Pediatr Blood Cancer; 2005 Aug; 45(2):111-20. PubMed ID: 15782402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic impact of age in children and adolescents with acute lymphoblastic leukemia: data from the trials ALL-BFM 86, 90, and 95.
    Möricke A; Zimmermann M; Reiter A; Gadner H; Odenwald E; Harbott J; Ludwig WD; Riehm H; Schrappe M
    Klin Padiatr; 2005; 217(6):310-20. PubMed ID: 16307416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorescence in situ hybridization study of TEL/AML1 fusion and other abnormalities involving TEL and AML1 genes. Correlation with cytogenetic findings and prognostic value in children with acute lymphocytic leukemia.
    Martínez-Ramírez A; Urioste M; Contra T; Cantalejo A; Tavares A; Portero JA; López-Ibor B; Bernacer M; Soto C; Cigudosa JC; Benítez J
    Haematologica; 2001 Dec; 86(12):1245-53. PubMed ID: 11726315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of diagnostic and relapse flow cytometry phenotypes in childhood acute lymphoblastic leukemia: implications for residual disease detection: a report from the children's oncology group.
    Borowitz MJ; Pullen DJ; Winick N; Martin PL; Bowman WP; Camitta B
    Cytometry B Clin Cytom; 2005 Nov; 68(1):18-24. PubMed ID: 16184615
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential mRNA expression of glucocorticoid receptor alpha and beta is associated with glucocorticoid sensitivity of acute lymphoblastic leukemia in children.
    Koga Y; Matsuzaki A; Suminoe A; Hattori H; Kanemitsu S; Hara T
    Pediatr Blood Cancer; 2005 Aug; 45(2):121-7. PubMed ID: 15704223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initial P-glycoprotein expression in childhood acute lymphoblastic leukemia: no evidence of prognostic impact in follow-up.
    Kanerva J; Tiirikainen MI; Mäkipernaa A; Riikonen P; Möttönen M; Salmi TT; Krusius T; Saarinen-Pihkala UM
    Pediatr Hematol Oncol; 2001; 18(1):27-36. PubMed ID: 11205837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children.
    Goto H; Naruto T; Tanoshima R; Kato H; Yokosuka T; Yanagimachi M; Fujii H; Yokota S; Komine H
    Leuk Res; 2009 Oct; 33(10):1386-91. PubMed ID: 19157546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.